<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/274F2FB0-27BB-4991-A894-796A2AE916E3"><gtr:id>274F2FB0-27BB-4991-A894-796A2AE916E3</gtr:id><gtr:name>The Christie NHS Foundation Trust</gtr:name><gtr:address><gtr:line1>Wilmslow Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M20 4BX</gtr:postCode><gtr:region>North West</gtr:region></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:department>Physics and Astronomy</gtr:department><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/274F2FB0-27BB-4991-A894-796A2AE916E3"><gtr:id>274F2FB0-27BB-4991-A894-796A2AE916E3</gtr:id><gtr:name>The Christie NHS Foundation Trust</gtr:name><gtr:address><gtr:line1>Wilmslow Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M20 4BX</gtr:postCode><gtr:region>North West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/3F6D208C-3F0C-473B-A4DC-58271F6DC1FE"><gtr:id>3F6D208C-3F0C-473B-A4DC-58271F6DC1FE</gtr:id><gtr:name>Christie Hospital NHS Trust</gtr:name><gtr:address><gtr:line1>Wilmslow Road</gtr:line1><gtr:line4>Manchester</gtr:line4><gtr:postCode>M20 4BX</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/FF612C7A-5A84-44CB-91B4-B01C95AE355C"><gtr:id>FF612C7A-5A84-44CB-91B4-B01C95AE355C</gtr:id><gtr:firstName>Andrew</gtr:firstName><gtr:surname>Robinson</gtr:surname><gtr:roles><gtr:role><gtr:name>RESEARCHER</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/99C41D61-B990-4324-B666-A7EB9D08E441"><gtr:id>99C41D61-B990-4324-B666-A7EB9D08E441</gtr:id><gtr:firstName>David Matthew</gtr:firstName><gtr:surname>Cullen</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=ST%2FK002945%2F1"><gtr:id>88C13BE9-7E96-4D3A-BB5B-922F95AB44EF</gtr:id><gtr:title>Invited Resubmission: Improved Organ Dose Determination and Imaging in 177Lu Targeted Radionuclide Therapy - towards a clinical solution.</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>ST/K002945/1</gtr:grantReference><gtr:abstractText>With this grant we will develop a far more accurate way of processing medical images from patients receiving cancer therapy using radioactive materials that target their tumours, known as Targeted Radionuclide Therapy (TRT). These images, taken using a hospital SPECT (Single Photon Emission Computed Tomography) scanner, are typically quite blurry and it is often difficult to distinguish tumours from normal healthy tissue. Based on our previous findings, by modelling the SPECT scanner system on a computer we will create a range of corrections that improve the accuracy of the information from these images. 

Our collaboration has successfully shown that we can significantly improve this accuracy for a variety of simple models representing the human body. We now wish to use this work as the basis of an advanced technique which will provide the same improvements for data from more detailed models of the human body and ultimately for actual patients receiving cancer therapy. This information will be used to provide doctors with an accurate measurement of the radiation dose delivered to the tumours and critical organs in the patient's body.

Using current commercial SPECT images, the uncertainties in dose estimation do not allow treatments to be optimised and consequently a significant proportion of patients do not receive the optimal therapy. Identification of these patients is problematic due to the current low accuracy of dose measurements. Having this improved dose information will help doctors to improve their therapies, potentially reducing side effects and hospital stays. This will improve the patients' therapy experience and also improve the efficacy of the therapies by allowing the doctors to optimise the treatment for each patient. Only by improving the accuracy of the images obtained from the SPECT scanner can we provide this information. 

Accurate dose information is considered very important in countries across Europe. Legislation is currently being written recommending accurate dosimetry for every patient receiving Targeted Radionuclide Therapy treatment. Our research will concentrate on improving the dose information for therapies using the isotope 177Lu. Recent work has shown that new treatments using this isotope can improve a patient's life expectancy by several years compared with other therapies, particularly for tumours affecting the hormonal and nervous systems. 
Our research will provide the basis for developing a commercial solution that will allow the techniques developed from this grant to be used in clinical departments performing cancer therapy with 177Lu. However, it can be extended to cover the complete range of isotopes commonly used for therapy and for images from different models of SPECT scanner. We have already approached two commercial companies who are interested in helping bring this research to market. This has the potential to provide a significant improvement in the outcome of an estimated 201,000 such therapies performed annually in Europe.</gtr:abstractText><gtr:fund><gtr:end>2014-09-30</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/D7F4F462-0518-4784-908A-D12633C139B3"><gtr:id>D7F4F462-0518-4784-908A-D12633C139B3</gtr:id><gtr:name>STFC</gtr:name></gtr:funder><gtr:start>2012-10-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>195466</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>The Christie NHS Foundation Trust</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Christie Medical Physics and Engineering</gtr:department><gtr:description>The Christie NHS Foundation Trust, Nuclear Medicine Department.</gtr:description><gtr:id>73608C05-B8EB-4D88-8730-34CD96265948</gtr:id><gtr:impact>This collaboration has delivered improved activity quantification for Molecular Radio Therapy at The Christie which provide the foundation of accurate and optimised patient dose calculations.

The research output from this collaboration has provided improved activity quantification and validation of exiting Molecular Radio Therapy dosimetry software.

The collaboration has submitted two research papers on this work.</gtr:impact><gtr:partnerContribution>The Christie has provide access to anonymised patient data, clinical SPECT cameras, Molecular Radio Therapy (MRT) isotopes and current MRT dosimetry software which has allowed the techniques developed in this work to be translate to a clinical environment. The research output from this collaboration has provided improved activity quantification and validation of exiting MRT dosimetry software.</gtr:partnerContribution><gtr:piContribution>We have provided the physics expertise needed to deliver improved dose calculations for Molecular Radiotherapy treatments at The Christie. This work has combined existing expertise in Monte-Carlo simulation, from basic nuclear physics research, and novel new 3D printing techniques. This collaboration has already delivered improved activity quantification for MRT at The Christie which provide the foundation of accurate and optimised patient dose calculations.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description> Presented Poster at European Association Nuclear Medicine, Hamburg October 2015</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>70DC1ABA-C3A6-46EE-8C00-EB3EDAE3B02B</gtr:id><gtr:impact>Presented poster which sparked conversations and discsussions about 90Y SPECT dosimetry</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description> Institute of Physics Annual Conference, Manchester  2015</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>3EDEA362-4F2A-4098-95A8-A3AB62D78482</gtr:id><gtr:impact>Presented a talk on 90Y SPECT dosimetry.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Dalton Day symposium, The University of Manchester November 2014</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>88F9773C-AC36-4160-905A-A606E6F1D922</gtr:id><gtr:impact>Presented talk to Dalton students who work in industry.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Nuclear Head Start programme.</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>78B59E42-603C-4E1F-B681-5049DED80EB0</gtr:id><gtr:impact>Presentation on applied nuclear medical physics research and associated career opportunities.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:url>http://www.etrust.org.uk/nuclear-physics-manchester</gtr:url><gtr:year>2014,2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>MetroMRT (Molecular Radiotherapy) Workshops</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>9C834A9B-8158-4292-A8D4-13C930712158</gtr:id><gtr:impact>Presented latest research developments to the EU EMPIR-MetroMRT project.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://projects.npl.co.uk/metromrt</gtr:url><gtr:year>2013,2014,2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Presented poster at  British Nuclear Medicine Society, Brighton, April 2015</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>072CA63E-658D-4DE7-9823-1560F03EBF7A</gtr:id><gtr:impact>Presented poster which parked questions and debates afterwards.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Nuclear Medicine Conference presentations</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>246A64EF-3B2C-4CC3-9C83-F98669E537CA</gtr:id><gtr:impact>Presentations at:
1. British Nuclear Medecine Society annual meetings.
2. European Association of Nuclear medicine Congress.
3. International Conference on Medical Physics.
4. Nuclear Symposium on Science in Society.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2013,2014,2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description> Presented Talk at  internal Dosimerty Users Group meeting at The Christie Hospital NHS Trust, October 2015</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>B7ACC6AF-A3DC-4153-8176-F0D8FACE72D3</gtr:id><gtr:impact>Presented talk which sparked questions and debate about 90Y SPECT Dosimetry.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>80000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>STFC Industrial Case Award - Improving the image clarity and dosimetry accuracy for Selective Internal Radiotherapy using 90Y microspheres.</gtr:description><gtr:end>2017-09-02</gtr:end><gtr:fundingOrg>Science and Technologies Facilities Council (STFC)</gtr:fundingOrg><gtr:fundingRef>ST/K005618/1</gtr:fundingRef><gtr:id>CF133182-B404-449C-BA68-CB5B19D3ED6A</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>80000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>STFC Industrial Case Award - Validation of clinical radionuclide therapy dose distribution by a novel system of 3D printed anthropomorphic phantoms.</gtr:description><gtr:end>2019-10-02</gtr:end><gtr:fundingOrg>Science and Technologies Facilities Council (STFC)</gtr:fundingOrg><gtr:fundingRef>ST/M003302/1</gtr:fundingRef><gtr:id>EBE7F680-6213-447B-8852-224484D40447</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-09-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs><gtr:impactSummaryOutput><gtr:description>The outputs from this work have been used to improve the accuracy of dosimetry calculations which are currently used on patients for research at the Chrsitie Hospital.</gtr:description><gtr:firstYearOfImpact>2011</gtr:firstYearOfImpact><gtr:id>1B4F3F8B-A40C-4FBB-9EFF-645B5A1EC8C0</gtr:id><gtr:impactTypes><gtr:impactType>Policy &amp; public services</gtr:impactType></gtr:impactTypes><gtr:sector>Healthcare</gtr:sector></gtr:impactSummaryOutput></gtr:impactSummaryOutputs><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>We have discovered a way to improve the dosimetry of patients undergoing targeted molecular radiotherapy at the Chrisitie Hospital. This should lead to improved patient prognosis as more optimised or patient specific healthcare may ultimately become possible with more accurate dosimetry.</gtr:description><gtr:exploitationPathways>We are working with an Industrial partner Hermes Medical Solutions Ltd who will untimately market this research via a licence agreement once the full validation is achieved.</gtr:exploitationPathways><gtr:id>429B6602-F321-411D-86F7-7F3F792BBFE8</gtr:id><gtr:sectors><gtr:sector>Healthcare,Other</gtr:sector></gtr:sectors></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Change to clinical dosimetry procedure for low activity SPECT scans.</gtr:description><gtr:geographicReach>Local/Municipal/Regional</gtr:geographicReach><gtr:id>B83C7D2D-B5C2-4DE3-BD27-497043C5CEAF</gtr:id><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/68FF733B-C99D-4C12-9E7D-A48E46DF9B72"><gtr:id>68FF733B-C99D-4C12-9E7D-A48E46DF9B72</gtr:id><gtr:title>Organ-specific SPECT activity calibration using 3D printed phantoms for molecular radiotherapy dosimetry.</gtr:title><gtr:parentPublicationTitle>EJNMMI physics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/da2f4204b44b822c2c0ee2b821c44a69"><gtr:id>da2f4204b44b822c2c0ee2b821c44a69</gtr:id><gtr:otherNames>Robinson AP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2197-7364</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/0DC1B0FD-C46D-4F06-A7F5-4C1BFB1317A6"><gtr:id>0DC1B0FD-C46D-4F06-A7F5-4C1BFB1317A6</gtr:id><gtr:title>The influence of triple energy window scatter correction on activity quantification for (1 7 7)Lu molecular radiotherapy.</gtr:title><gtr:parentPublicationTitle>Physics in medicine and biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/da2f4204b44b822c2c0ee2b821c44a69"><gtr:id>da2f4204b44b822c2c0ee2b821c44a69</gtr:id><gtr:otherNames>Robinson AP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0031-9155</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">ST/K002945/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects><gtr:researchSubject><gtr:id>6FFDB010-9050-4605-B449-A6952906EB9D</gtr:id><gtr:percentage>60</gtr:percentage><gtr:text>Nuclear Physics</gtr:text></gtr:researchSubject><gtr:researchSubject><gtr:id>FB535BD0-E265-4C0A-8532-32DCB83A3951</gtr:id><gtr:percentage>40</gtr:percentage><gtr:text>Tools, technologies &amp; methods</gtr:text></gtr:researchSubject></gtr:researchSubjects><gtr:researchTopics><gtr:researchTopic><gtr:id>A759BB04-AFFE-4780-BD31-9A2707BC44BA</gtr:id><gtr:percentage>40</gtr:percentage><gtr:text>Medical Imaging</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>00C03EE8-351D-40B5-A0D4-06C45592BFF6</gtr:id><gtr:percentage>60</gtr:percentage><gtr:text>Nuclear structure</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>